Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

High prevalence of spondyloarthritis in sarcoidosis patients with chronic back pain.

Sigaux J, Semerano L, Nasrallah T, Nunes H, Bouvry D, Valeyre D, Boissier MC, Saidenberg-Kermanac'h N.

Semin Arthritis Rheum. 2019 Mar 11. pii: S0049-0172(18)30778-9. doi: 10.1016/j.semarthrit.2019.03.006. [Epub ahead of print]

PMID:
31138443
2.

From coagulation to inflammation: novel avenues for treating rheumatoid arthritis with activated protein C.

Boissier MC, Semerano L.

Rheumatology (Oxford). 2019 May 23. pii: kez200. doi: 10.1093/rheumatology/kez200. [Epub ahead of print] No abstract available.

PMID:
31121036
3.

Microenvironment tailors nTreg structure and function.

Schiavon V, Duchez S, Branchtein M, How-Kit A, Cassius C, Daunay A, Shen Y, Dubanchet S, Colisson R, Vanneaux V, Pruvost A, Roucairol C, Setterblad N, Bouaziz JD, Boissier MC, Semerano L, Graux C, Bensussan A, Burny A, Gallo R, Zagury D, Le Buanec H.

Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6298-6307. doi: 10.1073/pnas.1812471116. Epub 2019 Mar 7.

4.

Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37.

Ribon M, Seninet S, Mussard J, Sebbag M, Clavel C, Serre G, Boissier MC, Semerano L, Decker P.

J Autoimmun. 2019 Mar;98:122-131. doi: 10.1016/j.jaut.2019.01.003. Epub 2019 Jan 28.

PMID:
30704942
5.

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P.

N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.

6.

Switch to a biosimilar: Whatever the cost?

Sigaux J, Semerano L, Boissier MC.

Joint Bone Spine. 2018 Dec;85(6):651-654. doi: 10.1016/j.jbspin.2018.09.007. Epub 2018 Sep 20. No abstract available.

PMID:
30244125
7.

Air pollution as a determinant of rheumatoid arthritis.

Sigaux J, Biton J, André E, Semerano L, Boissier MC.

Joint Bone Spine. 2019 Jan;86(1):37-42. doi: 10.1016/j.jbspin.2018.03.001. Epub 2018 Mar 7.

PMID:
29524589
8.

Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection.

Belmellat N, Semerano L, Segueni N, Damotte D, Decker P, Ryffel B, Quesniaux V, Boissier MC, Assier E.

Front Immunol. 2017 Nov 14;8:1533. doi: 10.3389/fimmu.2017.01533. eCollection 2017.

9.

Salt, inflammatory joint disease, and autoimmunity.

Sigaux J, Semerano L, Favre G, Bessis N, Boissier MC.

Joint Bone Spine. 2018 Jul;85(4):411-416. doi: 10.1016/j.jbspin.2017.06.003. Epub 2017 Jun 23.

PMID:
28652101
10.

Developments with experimental and investigational drugs for axial spondyloarthritis.

Clavel G, Boissier MC, Sigaux J, Semerano L.

Expert Opin Investig Drugs. 2017 Jul;26(7):833-842. doi: 10.1080/13543784.2017.1337744. Epub 2017 Jun 6. Review.

PMID:
28562100
11.

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.

Juge PA, Borie R, Kannengiesser C, Gazal S, Revy P, Wemeau-Stervinou L, Debray MP, Ottaviani S, Marchand-Adam S, Nathan N, Thabut G, Richez C, Nunes H, Callebaut I, Justet A, Leulliot N, Bonnefond A, Salgado D, Richette P, Desvignes JP, Lioté H, Froguel P, Allanore Y, Sand O, Dromer C, Flipo RM, Clément A, Béroud C, Sibilia J, Coustet B, Cottin V, Boissier MC, Wallaert B, Schaeverbeke T, Dastot le Moal F, Frazier A, Ménard C, Soubrier M, Saidenberg N, Valeyre D, Amselem S; FREX consortium, Boileau C, Crestani B, Dieudé P.

Eur Respir J. 2017 May 11;49(5). pii: 1602314. doi: 10.1183/13993003.02314-2016. Print 2017 May.

12.

Do we need animal models to advance research on inflammatory joint disease?

Boissier MC, Bessis N.

Joint Bone Spine. 2017 Jul;84(4):381-383. doi: 10.1016/j.jbspin.2017.04.005. Epub 2017 Apr 26. Review. No abstract available.

PMID:
28456601
13.

Arthritis models: usefulness and interpretation.

Bessis N, Decker P, Assier E, Semerano L, Boissier MC.

Semin Immunopathol. 2017 Jun;39(4):469-486. doi: 10.1007/s00281-017-0622-4. Epub 2017 Mar 27. Review.

PMID:
28349194
14.

Vitamin D supplementation in patients treated for sarcoidosis: Controversy or consensus?

Saidenberg-Kermanac'h N, Valeyre D, Boissier MC.

Joint Bone Spine. 2017 Oct;84(5):521-523. doi: 10.1016/j.jbspin.2017.03.003. Epub 2017 Mar 18. Review. No abstract available.

PMID:
28323225
15.

IL-1 Vaccination Is Suitable for Treating Inflammatory Diseases.

Assier E, Bessis N, Zagury JF, Boissier MC.

Front Pharmacol. 2017 Jan 31;8:6. doi: 10.3389/fphar.2017.00006. eCollection 2017. No abstract available.

16.

Nutrition and chronic inflammatory rheumatic disease.

Semerano L, Julia C, Aitisha O, Boissier MC.

Joint Bone Spine. 2017 Oct;84(5):547-552. doi: 10.1016/j.jbspin.2016.10.003. Epub 2016 Nov 30. Review.

PMID:
27914804
17.

Developments with investigational Janus kinase inhibitors for rheumatoid arthritis.

Semerano L, Decker P, Clavel G, Boissier MC.

Expert Opin Investig Drugs. 2016 Dec;25(12):1355-1359. Epub 2016 Oct 31. No abstract available.

PMID:
27748152
18.

Personality modulates proportions of CD4+ regulatory and effector T cells in response to socially induced stress in a rodent of wild origin.

Rangassamy M, Khaleghparast Athari S, Monclús R, Boissier MC, Bessis N, Rödel HG.

Physiol Behav. 2016 Dec 1;167:255-264. doi: 10.1016/j.physbeh.2016.09.016. Epub 2016 Sep 22.

PMID:
27666163
19.

Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review.

Minichiello E, Semerano L, Boissier MC.

Joint Bone Spine. 2016 Dec;83(6):625-630. doi: 10.1016/j.jbspin.2016.07.007. Epub 2016 Sep 5.

PMID:
27616690
20.

In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis.

Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, Delavallée L, Levescot A, Roga S, Decker P, Girard JP, Herbelin A, Boissier MC, Bessis N.

J Immunol. 2016 Sep 1;197(5):1708-19. doi: 10.4049/jimmunol.1502124. Epub 2016 Jul 29.

21.

Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.

Athari SK, Poirier E, Biton J, Semerano L, Hervé R, Raffaillac A, Lemeiter D, Herbelin A, Girard JP, Caux F, Boissier MC, Bessis N.

Arthritis Res Ther. 2016 Jun 18;18(1):143. doi: 10.1186/s13075-016-1042-x.

22.

Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.

Semerano L, Minichiello E, Bessis N, Boissier MC.

Trends Mol Med. 2016 Mar;22(3):214-229. doi: 10.1016/j.molmed.2016.01.005. Epub 2016 Feb 12. Review.

PMID:
26875450
23.

Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis.

Denys A, Clavel G, Lemeiter D, Schischmanoff O, Boissier MC, Semerano L.

J Cell Mol Med. 2016 May;20(5):855-63. doi: 10.1111/jcmm.12790. Epub 2016 Feb 9.

24.

Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort.

Vandhuick T, Allanore Y, Borderie D, Louvel JP, Fardellone P, Dieudé P, Goëb V, Clavel G, Boissier MC, Jouen F, Boumier P, Allart JD, Mejjad O, Pouplin S, Jan M, Ménard JF, Le Loët X, Vittecoq O.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):58-67. Epub 2015 Dec 20.

PMID:
26744355
25.

Teriparatide for osteoporosis in patients with sarcoidosis: Report on risk-benefit ratio in four cases.

Challal S, Semerano L, Nunes H, Valeyre D, Boissier MC, Saidenberg-Kermanac'h N.

Joint Bone Spine. 2016 May;83(3):344-5. doi: 10.1016/j.jbspin.2015.11.007. Epub 2015 Dec 18.

PMID:
26709249
26.

Calpains Released by T Lymphocytes Cleave TLR2 To Control IL-17 Expression.

Perez J, Dansou B, Hervé R, Levi C, Tamouza H, Vandermeersch S, Demey-Thomas E, Haymann JP, Zafrani L, Klatzmann D, Boissier MC, Letavernier E, Baud L.

J Immunol. 2016 Jan 1;196(1):168-81. doi: 10.4049/jimmunol.1500749. Epub 2015 Nov 25.

27.

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis.

Semerano L, Duvallet E, Belmellat N, Marival N, Schall N, Monteil M, Grouard-Vogel G, Bernier E, Lecouvey M, Hlawaty H, Muller S, Boissier MC, Assier E.

Angiogenesis. 2016 Jan;19(1):39-52. doi: 10.1007/s10456-015-9487-0. Epub 2015 Sep 29.

PMID:
26419779
28.

Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes.

Challal S, Minichiello E, Boissier MC, Semerano L.

Joint Bone Spine. 2016 Mar;83(2):127-33. doi: 10.1016/j.jbspin.2015.04.010. Epub 2015 Jul 14. Review.

PMID:
26184539
29.

Ehlers-Danlos syndrome in rheumatology: Diagnostic and therapeutic challenges.

Challal S, Minichiello E, Funalot B, Boissier MC.

Joint Bone Spine. 2015 Oct;82(5):305-7. doi: 10.1016/j.jbspin.2015.04.002. Epub 2015 May 23. No abstract available.

PMID:
26005130
30.

Metabolomics for rheumatic diseases: has the time come?

Semerano L, Roméo PH, Boissier MC.

Ann Rheum Dis. 2015 Jul;74(7):1325-6. doi: 10.1136/annrheumdis-2014-206618. Epub 2015 Jan 21. No abstract available.

PMID:
25609411
31.

Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial.

Durez P, Vandepapeliere P, Miranda P, Toncheva A, Berman A, Kehler T, Mociran E, Fautrel B, Mariette X, Dhellin O, Fanget B, Ouary S, Grouard-Vogel G, Boissier MC.

PLoS One. 2014 Dec 17;9(12):e113465. doi: 10.1371/journal.pone.0113465. eCollection 2014.

32.

Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice.

Thiolat A, Denys A, Petit M, Biton J, Lemeiter D, Herve R, Lutomski D, Boissier MC, Bessis N.

Cytokine. 2014 Sep;69(1):87-93. doi: 10.1016/j.cyto.2014.05.015. Epub 2014 Jun 11.

PMID:
25022966
33.

Reply: To PMID 24504799.

Thiolat A, Biton J, Decker P, Semerano L, Boissier MC, Pers YM, Jorgensen C, Plence PL, Bessis N.

Arthritis Rheumatol. 2014 Sep;66(9):2640-1. doi: 10.1002/art.38717. No abstract available.

34.

Targeting IL-6 for the treatment of rheumatoid arthritis: Phase II investigational drugs.

Semerano L, Thiolat A, Minichiello E, Clavel G, Bessis N, Boissier MC.

Expert Opin Investig Drugs. 2014 Jul;23(7):979-99. doi: 10.1517/13543784.2014.912276. Epub 2014 Apr 26. Review.

PMID:
24766460
35.

Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients.

Saidenberg-Kermanac'h N, Semerano L, Nunes H, Sadoun D, Guillot X, Boubaya M, Naggara N, Valeyre D, Boissier MC.

Arthritis Res Ther. 2014 Mar 24;16(2):R78. doi: 10.1186/ar4519.

36.

Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.

Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N.

Arthritis Rheumatol. 2014 Feb;66(2):273-83. doi: 10.1002/art.38246.

37.

TLR9 independent interferon α production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen.

Lindau D, Mussard J, Rabsteyn A, Ribon M, Kötter I, Igney A, Adema GJ, Boissier MC, Rammensee HG, Decker P.

Ann Rheum Dis. 2014 Dec;73(12):2199-207. doi: 10.1136/annrheumdis-2012-203041. Epub 2013 Sep 7.

PMID:
24013727
38.

Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38.

Clavel G, Thiolat A, Boissier MC.

Joint Bone Spine. 2013 Oct;80(5):449-53. doi: 10.1016/j.jbspin.2013.04.014. Epub 2013 Jul 9. Review.

PMID:
23849463
39.

Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence.

Derré-Bobillot A, Cortes-Perez NG, Yamamoto Y, Kharrat P, Couvé E, Da Cunha V, Decker P, Boissier MC, Escartin F, Cesselin B, Langella P, Bermúdez-Humarán LG, Gaudu P.

Mol Microbiol. 2013 Aug;89(3):518-31. doi: 10.1111/mmi.12295. Epub 2013 Jul 5.

40.

Primary blood neutrophils express a functional cell surface Toll-like receptor 9.

Lindau D, Mussard J, Wagner BJ, Ribon M, Rönnefarth VM, Quettier M, Jelcic I, Boissier MC, Rammensee HG, Decker P.

Eur J Immunol. 2013 Aug;43(8):2101-13. doi: 10.1002/eji.201142143.

41.

Benchmarking biomedical publications worldwide.

Boissier MC.

Rheumatology (Oxford). 2013 Sep;52(9):1545-6. doi: 10.1093/rheumatology/ket181. Epub 2013 May 10. No abstract available.

PMID:
23667184
42.

Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels.

Semerano L, Biton J, Delavallée L, Duvallet E, Assier E, Bessis N, Bernier E, Dhellin O, Grouard-Vogel G, Boissier MC.

Clin Exp Immunol. 2013 Apr;172(1):54-62. doi: 10.1111/cei.12040.

43.

Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting.

Saidenberg-Kermanac'h N, Semerano L, Naccache JM, Brauner M, Falgarone G, Dumont-Fischer D, Guillot X, Valeyre D, Boissier MC.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1307-14. doi: 10.5588/ijtld.12.0111. Epub 2012 Aug 3.

PMID:
22863801
44.

Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction.

Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G.

J Autoimmun. 2012 Sep;39(3):222-8. doi: 10.1016/j.jaut.2012.05.021. Epub 2012 Jun 16. Review.

PMID:
22704962
45.

B-cell targeted treatments for lupus: the journey counts as much as the destination.

Falgarone G, Dhote R, Boissier MC.

Joint Bone Spine. 2012 Oct;79(5):437-40. doi: 10.1016/j.jbspin.2012.02.010. Epub 2012 Apr 4. Review.

PMID:
22480746
46.

The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering.

Singh-Jasuja H, Thiolat A, Ribon M, Boissier MC, Bessis N, Rammensee HG, Decker P.

Immunobiology. 2013 Jan;218(1):28-39. doi: 10.1016/j.imbio.2012.01.021. Epub 2012 Feb 21.

PMID:
22445076
47.

Modulation of anti-tumor necrosis factor alpha (TNF-α) antibody secretion in mice immunized with TNF-α kinoid.

Assier E, Semerano L, Duvallet E, Delavallée L, Bernier E, Laborie M, Grouard-Vogel G, Larcier P, Bessis N, Boissier MC.

Clin Vaccine Immunol. 2012 May;19(5):699-703. doi: 10.1128/CVI.05649-11. Epub 2012 Mar 21.

48.

Anti-cytokine vaccination: a new biotherapy of autoimmunity?

Semerano L, Assier E, Boissier MC.

Autoimmun Rev. 2012 Sep;11(11):785-6. doi: 10.1016/j.autrev.2012.02.003. Epub 2012 Feb 12. Review.

PMID:
22349621
49.

Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells.

Rullé S, Ah Kioon MD, Asensio C, Mussard J, Ea HK, Boissier MC, Lioté F, Falgarone G.

Immunology. 2012 Jun;136(2):252-64. doi: 10.1111/j.1365-2567.2012.03577.x.

50.

TNFα: activator or inhibitor of regulatory T cells?

Biton J, Boissier MC, Bessis N.

Joint Bone Spine. 2012 Mar;79(2):119-23. doi: 10.1016/j.jbspin.2011.09.017. Epub 2011 Dec 29. Review.

PMID:
22209316

Supplemental Content

Loading ...
Support Center